Taspoglutide
Links shared publicly online about this topic
A Bad Day for Diabetes Drugs: Avandia and taspoglutide | Reporting on Health
reportingonhealth.org — “It's a dismal day for diabetes drugs, with new research showing that Avandia raises the risks for heart disease and stroke and problematic side effects reported for taspoglutide, an experimental diabetes drug from Roche that was expected to be a huge” View full resource at reportingonhealth.org
Most Recently Shared on June 28, 2010 at 5:14 pm By:
Reporting on Health Health Organization
A Bad Day for #Diabetes Drugs: #Avandia and taspoglutide http://bit.ly/ccLfCO #pharma #health #journalism
Roche dumps taspoglutide as analysts read last rites - FierceBiotech
fiercebiotech.com — “Roche is cutting its losses on the once-promising diabetes drug taspoglutide, returning the rights it had licensed from Ipsen after the therapy was torpedoed in late-stage trials by unexpected side Read more...” View full resource at fiercebiotech.com
Most Recently Shared on February 1, 2011 at 2:15 pm By:
Roche dumps taspoglutide as analysts read last rites. http://bit.ly/gfERBo
Roche Halts Taspoglutide Dosing in Final Studies - BusinessWeek
businessweek.com — “Roche Holding AG told researchers to stop giving its experimental diabetes drug taspoglutide to patients in the final studies needed for approval after side effects such as nausea and vomiting led many to drop out of the trials.” View full resource at businessweek.com
Most Recently Shared on September 10, 2010 at 6:49 pm By:
RT @DiabetesNews Roche Halts Taspoglutide Dosing in Final Diabetes Studies - BusinessWeek http://is.gd/f4uZH
Roche announces results of phase III taspoglutide study in diabetes patients
news-medical.net — “Ipsen, an innovation-driven global specialty pharmaceutical group, today announced that its partner Roche has disclosed the results of the second and third of eight T-emerge phase III studies in patients with diabetes for taspoglutide, the first human once weekly glucagon-like peptide-1 (GLP-1) analogue originating from Ipsen's research and developed by Roche.” View full resource at news-medical.net
Most Recently Shared on December 2, 2009 at 2:44 pm By:
Stroke News: Roche announces results of phase III taspoglutide study in diabetes patients: Ipsen, an innovation-d... http://twurl.nl/30bptc
Ipsen's Partner Roche Announces That Taspoglutide Meets Its Primary Endpoint In The First Phase III Clinical Trial
medicalnewstoday.com — “Ipsen (paris:ipn), an innovation-driven global specialty pharmaceutical group, announced that its partner roche has disclosed the results of a first phase iii clinical study using taspoglutide, th” View full resource at medicalnewstoday.com
Most Recently Shared on October 29, 2009 at 9:10 pm By:
Ipsen's Partner Roche Announces That Taspoglutide Meets Its Primary Endpoint In The First Phase III Clinical Tr.. http://bit.ly/1rGDCT
Ipsen's Partner Roche Announces That Taspoglutide Meets Its Primary Endpoint In A Key Phase III Clinical Trial
medicalnewstoday.com — “Ipsen (Paris:IPN) (Euronext: FR0010259150; IPN), a global biopharmaceutical group, today announced that its partner Roche has disclosed results of the phase III T-emerge 3 study in patients with d” View full resource at medicalnewstoday.com
Most Recently Shared on April 30, 2010 at 1:07 pm By:
Ipsen's Partner Roche Announces That Taspoglutide Meets Its Primary Endpoint In A Key Phase III Clinical Trial http://mnt.to/3BWJ #diabetes
Experimental Diabetes Drug Taspoglutide Late-Stage Trials Suspended - QualityPoint Technologies
qualitypointtech.net — “Experimental diabetes drug, taspoglutide, a joint development between Roche (Switzerland) and Ipsen (France), had its late-stage trials suspended because of side effects. Roche announced that it had stopped giving patients taspoglutide because of adverse gastrointestinal reactions. The drug already has some” View full resource at qualitypointtech.net
Most Recently Shared on September 14, 2010 at 8:25 am By:
Experimental Diabetes Drug Taspoglutide Late-Stage Trials Suspended: Experimental diabetes drug, taspoglutide, a j... http://bit.ly/aNW3TJ
Despite showing superior glycemic control in recent studies, Roche halts all trials linked to taspoglutide
endocrinetoday.com — “EASD Annual Meeting Taspoglutide was superior to exenatide in terms of glycemic control in patients with type 2 diabetes, recent studies hav” View full resource at endocrinetoday.com
Most Recently Shared on September 29, 2010 at 3:34 pm By:
Despite showing superior glycemic control in recent studies, Roche halts all trials linked to taspoglutide http://ow.ly/2LKuk
EASD: Taspoglutide Beset By Gastro Problems (CME/CE) - QualityPoint Technologies
qualitypointtech.net — “STOCKHOLM (MedPage Today) -- The novel once-weekly injectable GLP-1 receptor agonist taspoglutide was better at improving glycated hemoglobin after six months than twice-daily exenatide (Byetta) -- but was plagued by the same gastrointestinal side effects that halted the T-Emerge series of trials, researchers said.” View full resource at qualitypointtech.net
Most Recently Shared on September 27, 2010 at 2:00 pm By:
EASD: Taspoglutide Beset By Gastro Problems (CME/CE): STOCKHOLM (MedPage Today) -- The novel once-weekly injectabl... http://bit.ly/djFRkV
Ipsen's Partner Roche Announces That Taspoglutide Meets Its Primary Endpoints In Head-to-Head Study With Sitagliptin (Januvia(R)) And Versus Placebo
medicalnewstoday.com — “Ipsen (euronext: fr0010259150; ipn), an innovation-driven global specialty pharmaceutical group, today announced that its partner roche has disclosed the results of the second and third of eight t” View full resource at medicalnewstoday.com
Most Recently Shared on December 2, 2009 at 6:42 pm By:
Ipsen's Partner Roche Announces That Taspoglutide Meets Its Primary Endpoints In Head-to-Head Study With Sitaglipti... http://bit.ly/5igddf
News: Roche suspends dosing in late stage clinical trials of experimental diabetes treatment taspoglutide http://bit.ly/b4IGA4 - #health
reuters.com — “News: Roche suspends dosing in late stage clinical trials of experimental diabetes treatment taspoglutide http://bit.ly/b4IGA4 - #health” View full resource at reuters.com
Most Recently Shared on September 11, 2010 at 5:45 am By:
Hisham Rana, MD Doctor and Physician
News: Roche suspends dosing in late stage clinical trials of experimental diabetes treatment taspoglutide http://bit.ly/b4IGA4 - #health
Roche to give decision on diabetes drug in Feb | Reuters
reuters.com — “LONDON, Dec 9 (Reuters) - Roche expects to announce whether or not it will continue developing experimental diabetes drug taspoglutide when it presents full-year financial results in early” View full resource at reuters.com
Most Recently Shared on December 9, 2010 at 12:08 pm By:
John Carroll Health Communicator
Final decision on Roche's disappointing taspoglutide program will be made in early Feb. http://reut.rs/hoKnt5
Roche suspends dosing in diabetes drug trials: NEW YORK (Reuters) - Roche Holding has stopped giving patients its ... http://bit.ly/aKAUgc
reuters.com — “Roche suspends dosing in diabetes drug trials: NEW YORK (Reuters) - Roche Holding has stopped giving patients its ... http://bit.ly/aKAUgc” View full resource at reuters.com
Most Recently Shared on September 10, 2010 at 11:02 pm By:
HealthIT Policy Health News and Health IT
Roche suspends dosing in diabetes drug trials: NEW YORK (Reuters) - Roche Holding has stopped giving patients its ... http://bit.ly/aKAUgc
Roche diabetes drug beats Januvia in Phase III - FierceBiotech
fiercebiotech.com — “Roche rolled out data from a pair of Phase III trials of its experimental diabetes drug taspoglutide, saying that researchers have nailed down its superiority to Merck's blockbuster Januvia. The Read more...” View full resource at fiercebiotech.com
Most Recently Shared on December 2, 2009 at 12:55 pm By:
BREAKING NEWS: Roche diabetes drug taspoglutide beats Januvia in Phase III. http://is.gd/59YIY
Roche diabetes trial proves promising | InPharm
inpharm.com — “Roche diabetes trial proves promising | InPharm” View full resource at inpharm.com
Most Recently Shared on February 11, 2010 at 12:44 pm By:
Pharmafocus Health News and Pharma
Roche diabetes trial proves promising. Taspoglutide shows positive effect on blood glucose in phase III trial. http://ow.ly/16gaq
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Reporting on Health
ReportingonHealth.org offers professional resources and community for journalists covering health issues. We're nonprofit, nonpartisan and educational.
-
FierceBiotech
FierceBiotech's 140, written by Managing Editor Maureen Martino. Join the largest and most active biotech news readership in the world at FierceBiotech.com.
-
Ronnie Gregory
I am an equal opportunity retweeter, Spreading Diabetes Awareness. Blogger and Diabetes Advocate.
Advertisement
